echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Rincazole is being studied for anti-cancer treatment

    Rincazole is being studied for anti-cancer treatment

    • Last Update: 2020-07-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Modern Biosciences has begun new research as a possible cancer drug, the former schizophrenia drug rimazole has announcedAnti-cancer studies of rincazole focused on sigma-1 receptorsThe receptor was originally thought to be an opioid receptor, and its ligand has the potential to treatof mentaldiseaseIt was not until 1996 when it was cloned that it was found to be homologous at the primary sequence level with traditional opioid receptorsDrBarbara Spruse and his team at the University of Dundee have shown for the first time that drugs such as rincazole that bind to sigma-1 receptors can causetumorscells (and nonnormal cells) tend to apoptosisAbout 20 years ago, there were unsuccessful clinical trials of rincazole for the treatment of schizophrenia, and there is a large amount of preclinical and clinical safety data available, so the development risk is considered lower than that of other generic drugsAccording to Modern Biosciences, the many features of rincazole make it a promising cancer candidateRincazole is a small molecular drug that can be taken orallyIt acts through a dual mechanism of action, which can strongly stimulate apoptosis and inhibit angiogenesis intumorIt can fight a variety of cancers, including those that are resistant to existing drugsIt's low-toxic The company plans to begin Phase I.b trials this year, which will monitor the growth of tumors and a series of biomarkers showing the progression of disease , and proof-of-concept data will be available within two years (Duan Wanru)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.